What you will learn:
- Opportunity to meet the PCSIG Board members
- Get updated on the current and future activities of PCSIG
- Find out how to get involved in PCSIG activities
PCSIG – Review of 2024
A review by the PCSIG Board highlighting our achievements in 2024, and our ongoing and planned future activities.
Members of the PCSIG Board will talk about a number of activities that the group has undertaken in 2024, along with plans for the future of the group and how you can get involved. This includes details of the establishment of the PCSIG Patient Advisory Group, the PCSIG Sponsors Advisory Group, our workshop "incorporating PCS approaches into multi-site clinical trials", our webinars, website and other activities aimed at increasing the awareness of patient centric sampling approaches and overcoming the barriers for their more widespread adoption.
Of interest to PCSIG members anyone passionate about the implementation of patient centric sampling.
Moderated by:
Neil Spooner
Director, Spooner Bioanalytical Solutions
Located in Hertford, UK, Neil is the Chair and co-founder of the PCSIG. He also runs a consultancy company where one of the main drivers is to help Clients understand the benefits of patient centric blood sampling, develop appropriate technologies and workflows and implement them for the benefit of human wellbeing.
Neil’s interest in these technologies began in 2007 whilst leading efforts at GlaxoSmithKline to find blood sampling and analysis approaches suitable for the measurement of pharmaceutical concentrations in samples obtained from children.
Joined by the PCSIG Board
Neil Spooner
Director, Spooner Bioanalytical Solutions
Located in Hertford, UK, Neil is the Chair and co-founder of the PCSIG. He also runs a consultancy company where one of the main drivers is to help Clients understand the benefits of patient centric blood sampling, develop appropriate technologies and workflows and implement them for the benefit of human wellbeing.
Neil’s interest in these technologies began in 2007 whilst leading efforts at GlaxoSmithKline to find blood sampling and analysis approaches suitable for the measurement of pharmaceutical concentrations in samples obtained from children.
Joined by the PCSIG Board
Share this webinar